FUCASO CAR-T Cell Therapy Package in Beijing, China by Bioocus International Medical Center

FUCASO: The Revolutionary Fully-Human BCMA CAR-T Therapy in Beijing, China

FUCASO, developed by Nanjing IASO Biotechnology, is a groundbreaking CAR-T Cell Therapy in Beijing, China specifically designed to target B-cell maturation antigen (BCMA). This therapy stands out for its unparalleled clinical efficacy and safety profile, providing a new hope for patients with relapsed or refractory multiple myeloma (r/rMM).

Approved by the National Medical Products Administration (NMPA) on June 30, 2023, FUCASO has already demonstrated significant success in clinical applications. CAR-T cell therapy by Bioocus International Medical Center is a groundbreaking treatment for certain types of cancer, offering new hope to patients who haven't responded to traditional therapies. 

Cost of FUCASO CAR-T Cell Therapy in Beijing, China

The FUCASO CAR-T Cell Therapy Price in Beijing, China by Bioocus International Medical Center with the price starts at $300,000. Please refer to our price list table below:

Location	Cost in USD
Beijing, China	$300,000
United States	$500,000
United Kingdom	$450,000

Note: price may change and vary depends on complexity of procedures and patient conditions. Click FREE QUOTE button below to learn more.

Advantages of Choosing FUCASO CAR-T Cell Therapy in Beijing, China

Clinical Success:

The first patient treated with FUCASO has achieved five years of cancer-free survival, a remarkable milestone compared to the median Progression-Free Survival (PFS) of just 2.9 months with standard care. This highlights FUCASO's potential to transform the treatment landscape for multiple myeloma.

Expansion and Future Development:

IASO BIO is committed to expanding the clinical applications of FUCASO beyond multiple myeloma to include autoimmune diseases and other hematologic malignancies. The company is also working on bringing this innovative therapy to global markets, ensuring more patients can benefit from its life-changing potential.

Overview of the FUCASO CAR-T Cell Therapy

The FUCASO CAR-T Cell Therapy procedure begins with the collection of T-cells from the patient’s blood. These T-cells are then genetically modified in a specialized laboratory to produce chimeric antigen receptors (CARs) on their surface. This modification enables the T-cells to recognize and attack specific cancer cells. After modification, the CAR-T cells are multiplied in the lab and then reintroduced into the patient’s body through infusion.

Once inside the body, the CAR-T cells circulate and seek out cancer cells, binding to them and initiating their destruction. This process can take several weeks, during which the patient is closely monitored. The therapy can lead to rapid and significant reductions in tumor size, and in many cases, complete remission. However, the process is complex and requires careful management by a team of specialized doctors and support staff.

FUCASO CAR-T Cell Therapy Package Inclusions

FUCASO CAR-T Cell Therapy Package Exclusions

• Travel and Accommodation: Patients are responsible for arranging their own travel to Beijing and accommodation during the treatment period.

• Additional Medical Tests: Any extra tests not directly related to the CAR-T therapy procedure are not included in the package.

• Post-Treatment Medications: Medications prescribed after the therapy for managing side effects or other conditions are not covered.

• Personal Expenses: Costs related to meals, personal items, and other non-medical needs are not included.

• Extended Hospital Stay: If the patient requires a longer hospital stay than initially planned, additional costs may apply.

FUCASO CAR-T Cell Therapy Pre-Op Tests

FUCASO CAR-T Cell Therapy Doctor in Beijing, China

At Bioocus International Medical Center, CAR-T cell therapy is expertly led by Dr. Daopei Lu, a distinguished oncologist renowned for his extensive experience in treating hematologic cancers. With over 20 years of dedicated service in the field, Dr. Lu has been instrumental in advancing CAR-T cell therapy, achieving remarkable success in numerous treatments. His profound expertise in immunotherapy and personalized medicine ensures that every patient receives a tailored and cutting-edge approach to their care. Dr. Lu is supported by a highly skilled team of nurses and laboratory technicians, all of whom share his commitment to delivering exceptional results.

Is the FUCASO CAR-T Cell Therapy Right for You?

• Refractory or Relapsed Blood Cancer: Ideal for patients whose cancer has not responded to traditional treatments.

• Good General Health: Suitable for patients who are otherwise healthy and can tolerate the treatment process.

• Commitment to Long-Term Follow-Up: Patients must be willing to engage in ongoing monitoring after treatment.

• Personalized Medicine: Best for those who are looking for a tailored approach to their cancer treatment.

• Desire for Innovative Treatment: CAR-T therapy is a cutting-edge option for those seeking the latest in cancer care.

What to Expect During the FUCASO CAR-T Cell Therapy in Beijing, China

FAQs (Frequently Asked Questions)

Get FREE QUOTE for FUCASO CAR-T Cell Therapy in Beijing, China!

Are you considering CAR-T Cell Therapy in China for your cancer treatment? Take the first step towards a healthier future by booking a consultation with Bioocus International Medical Center in Beijing, China through PlacidWay Medical Tourism. Our team is here to guide you through every step of the process, ensuring you receive the best care possible. Contact us today to learn more about how FUCASO CAR-T Cell Therapy can help you achieve lasting remission and improved quality of life.